BlackRock Inc. - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$63,138,839
-18.1%
11,585,108
+0.9%
0.00%0.0%
Q2 2023$77,048,158
-25.9%
11,482,587
-2.4%
0.00%
-33.3%
Q1 2023$103,915,335
+9.9%
11,768,441
-4.9%
0.00%0.0%
Q4 2022$94,538,865
+31.2%
12,374,197
+22.3%
0.00%
+50.0%
Q3 2022$72,051,000
-1.3%
10,119,409
+12.2%
0.00%0.0%
Q2 2022$72,982,000
-11.9%
9,021,108
+51.2%
0.00%0.0%
Q1 2022$82,814,000
-46.0%
5,966,501
+9.1%
0.00%
-50.0%
Q4 2021$153,487,000
-19.2%
5,469,989
-2.2%
0.00%
-20.0%
Q3 2021$190,012,000
-12.6%
5,590,226
+5.1%
0.01%
-16.7%
Q2 2021$217,369,000
+10.1%
5,319,857
+8.5%
0.01%0.0%
Q1 2021$197,398,000
-32.5%
4,903,045
-0.8%
0.01%
-33.3%
Q4 2020$292,336,000
+13.2%
4,943,939
-6.9%
0.01%
-10.0%
Q3 2020$258,271,000
-4.9%
5,310,912
-5.4%
0.01%
-9.1%
Q2 2020$271,636,000
+97.1%
5,614,608
+13.2%
0.01%
+57.1%
Q1 2020$137,812,000
+45.8%
4,960,832
+57.1%
0.01%
+75.0%
Q4 2019$94,505,000
+61.1%
3,158,549
+66.4%
0.00%
+100.0%
Q3 2019$58,646,000
+83.7%
1,897,927
+187.1%
0.00%
+100.0%
Q2 2019$31,925,000660,9830.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders